Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.22181 | 49 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.14455 | 48 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.15516 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.89661 | 41 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.11784 | 49 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.20593 | 47 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.22519 | 48 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.13026 | 48 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.15152 | 49 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.14051 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.24081 | 52 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.06058 | 47 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.14591 | 48 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.14118 | 48 |